Acute Myelogenous Leukemia (AML) Clinical Trials

A listing of Acute Myelogenous Leukemia (AML) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
Study Evaluating the Safety of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

(r/r) acute myeloid leukemia (AML).

fludarabine
cyclophosphamide
ejection fraction
gilbert's syndrome
refractory acute myeloid leukemia (aml)
  • 0 views
  • 07 Jun, 2021
  • 1 location
Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

A Randomized, Double-blind, Multiple-Dose, Two-Cycle, Parallel-Group, Bioequivalence pretrial of Daunorubicin Cytarabine liposome for Injection in older, naive patients with Acute Myeloid

ejection fraction
daunorubicin
cytarabine
  • 0 views
  • 16 Jun, 2021
  • 1 location
Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

patients with relapsed/refractory Acute Myeloid Leukemia (AML) and patients 65 years with initial diagnosis of AML. Primary objectives are: maximum tolerated dose (MTD) and dose

tacrolimus
azacitidine
induction chemotherapy
refractory acute myeloid leukemia (aml)
remission
  • 0 views
  • 12 Jun, 2021
  • 1 location
Liposomal Cytarabine Daunorubicin and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia

This phase I trial studies the best dose and side effects of liposomal cytarabine, daunorubicin, and gemtuzumab ozogamicin in treating pediatric patients with acute myeloid leukemia that has returned after treatment (relapsed) or does not respond to treatment (refractory). Chemotherapy drugs, such as liposomal cytarabine and daunorubicin, work in different …

  • 0 views
  • 13 Jun, 2021
  • 1 location
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

This phase I trial tests the side effects and best dose of abemaciclib and niraparib in treating patients with breast cancer that is positive for estrogen or progesterone receptors (hormone receptor positive [HR+]) and HER2 negative. Abemaciclib may stop the growth of tumor cells by blocking certain proteins called cyclin-dependent …

  • 0 views
  • 04 Jun, 2021
  • 1 location
Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia

This is a prospective,open-label, single center and single arm phase 1/2 study to evaluate the efficacy and safety of T cells expressing humanized CD7 chimeric antigen receptors treatment for patients with refractory/relapsed CD7 positive acute leukemia.

ejection fraction
acute leukemia
flow cytometry
  • 0 views
  • 11 Jun, 2021
  • 1 location
BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

To assess the efficacy, and safety of BST-236 in patients unfit for intensive chemotherapy with AML or HR MDS that failed or relapsed following first line therapy

cytarabine
ejection fraction
leukemia
acute leukemia
decitabine
  • 0 views
  • 16 Jun, 2021
  • 15 locations
Validation Study of a New Cytokine-based Dynamic Stratification Based on FLt3 Ligand Plasma Concentration Kinetic Profile and IL-6 Concentration During Induction of Acute Myeloid Leukemia

The investigators have recently demonstrated the strong impact in terms of survivals of Fms-like tyrosine kinase 3 ligand (FL) levels evaluated during intensive induction in acute myeloid

tyrosine
induction chemotherapy
leukapheresis
daunorubicin
gemtuzumab
  • 0 views
  • 15 Jun, 2021
  • 25 locations
Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphoma

The French Public Health Council recommended pneumococcal vaccination combined strategy for all immunocompromised patients in 2012. This strategy consisted in conjugated 13-valent pneumococcal injection followed 2 months later by polysaccharide 23-valent vaccine injection. General practitioners are usually in charge of this vaccination. Conjugated pneumococcal vaccine enhances the immunogenicity of the …

lymphoma
leukemia
acute leukemia
acute myeloblastic leukemia
23-valent vaccine
  • 0 views
  • 16 Jun, 2021
  • 4 locations